{"id":"W6964880994","doi":"10.3389/fimmu.2019.00040.s002","title":"Table_2_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.docx","year":2019,"lang":"en","type":"dataset","venue":"Figshare","topic":"Plant Ecology and Soil Science","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Adverse effect; Incidence (geometry); Antibody; Primary immunodeficiency; Intravenous Infusions","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005415166,0.0008321378,0.001320039,0.0007500923,0.000356574,0.0008992159,0.0007908933,0.0007494289,0.4046105],"category_scores_gemma":[0.002618766,0.0003094483,0.0009312716,0.0006171233,0.0001649732,0.000760008,0.0002285524,0.00120564,0.03709432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009774882,"about_ca_system_score_gemma":0.0008575043,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002507203,"about_ca_topic_score_gemma":0.007109369,"domain_scores_codex":[0.9997744,0.00005602051,0.00004075066,0.000023951,0.00006909915,0.00003569629],"domain_scores_gemma":[0.9978632,0.001051815,0.0003678795,0.00006852994,0.0004302162,0.0002182911],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01632296,0.001034948,0.002584025,0.00702264,0.0002485718,0.0002765273,0.00004107665,0.001016682,0.003071174,0.0008169827,0.8341271,0.1334373],"study_design_scores_gemma":[0.0536641,0.01351167,0.06328396,0.004253594,0.0005638343,0.002203642,0.0001651586,0.002194731,0.006498657,0.002216647,0.8512529,0.0001911348],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.02500005,0.01090082,0.001605684,0.008075143,0.001917445,0.00677525,0.8121076,0.002789456,0.1308284],"genre_scores_gemma":[0.159518,0.01355837,0.01151443,0.02955488,0.002768545,0.01159077,0.5123153,0.001036129,0.2581435],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.4046105,"threshold_uncertainty_score":0.8492509,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01897588123868441,"score_gpt":0.2387550619539724,"score_spread":0.219779180715288,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}